General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis Corporation(MODEST), Tempus Labs(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Janssen Pharmaceuticals, Inc(SIGNIFICANT) OTHER FINANCIAL BENEFIT: EasyG(NONE), physIQ(SIGNIFICANT)

View Full Disclosure